Menu
Back to Journals » OncoTargets and Therapy » Volume 11
Review
Encorafenib/binimetinib for the treatment of BRAF-mutant advanced, unresectable, or metastatic melanoma: design, development, and potential place in therapy
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 15,042 | Dovepress* | 9,518+ | 1,000 | 10,518 | |
| PubMed Central* | 5,524 | 723 | 6,247 | ||
| Totals | 15,042 | 1,723 | 16,765 | ||
| *Since 14 December 2018 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar